Atrial Fibrillation Trial, Recruiting NCT05777551 Sponsor: Clinica Mediterranea Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT05777551
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with a type of irregular heartbeat called atrial fibrillation (AF) that comes and goes or is ongoing, and who have agreed to take part by signing a consent form
  • People who are currently taking blood-thinning medication (anticoagulants) in tablet or capsule form

Who may not be able to join:

  • People who have previously had a procedure (ablation) to treat their atrial fibrillation
  • People whose heart pumping strength (ejection fraction) is below 35%, meaning the heart is significantly weakened
  • Women who may be pregnant
  • People who cannot be safely exposed to X-rays
  • People born with a heart defect, or those who have had heart surgery within the past month

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +393488960534

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Clinica Mediterranea
Registry
ClinicalTrials.gov
Start date
1 January 2023
Est. completion
31 December 2026

Where this trial is recruiting

🇫🇷 France 🇮🇹 Italy 🇬🇧 United Kingdom

Primary endpoints

Association between clinical and procedural characteristics and the percentage of arrhythmia recurrence rate after PV isolation performed with HPSD.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov